Watanabe Yoshihiro, Okafuji Ikuo, Tamai Satoko, Hosokawa Natsuko, Ohbayashi Takako, Kato Shigeki, Ito Kiyoaki, Kawano Mitsuhiro, Ohshima Yusei
IgG4-related Immunology, Graduate School of Medicine, Medical Science, Kanazawa University Hospital 13-1 Takara-machi, Kanazawa 920-8641, Ishikawa, Japan.
Pediatrics, Kobe City Medical Center General Hospital 2-1-1 Minatoshima Minami-cho, Chuo-ku, Kobe 650-0047, Japan.
J Immunol Methods. 2024 Dec;535:113773. doi: 10.1016/j.jim.2024.113773. Epub 2024 Nov 1.
Allergen-specific antibodies (Abs), IgE, and IgG4 increase during the early phase of oral immunotherapy (OIT) of allergen food in patients; subsequently, IgE levels decrease and specific IgG4 levels increase after successful OIT treatment. The detailed profile of these Abs during OIT remains largely unclear. We developed a diagnostic tool to assess the OIT efficacy and extent of responsiveness based on a profiling method by identifying epitopes recognized by the Ab classes of IgE or IgG4. A peptide microarray followed by microplate analysis using synthetic peptides was used to identify 14 epitopes widely recognized by IgE and/or IgG4 in the serum samples of patients with OIT among the amino acid sequences of five major cow's milk allergens. The set of defined 14 epitopes clarified different epitope profiles of allergen-specific IgE and IgG4 in each patient's serum samples. Moreover, the total signal of Abs recognizing all 14 epitopes was equal to the sum of all individual epitope-specific Abs. It was further observed that the quantitative value of IgE concentrations of 14 epitopes-ALL correlated with the ImmunoCAP IgE value. These findings strongly imply that the quantity of IgE and IgG4 recognizing epitopes-ALL may easily be used to measure allergy severity. To investigate this potential, we developed an immunochromatographic method that can detect IgE and IgG4 levels in patient samples. This study clearly demonstrated the usefulness of the defined 14 epitopes and their mixture, "epitopes-ALL," and that the simple and reliable methods of immunochromatography and microplate analyses demonstrating the epitope profile of allergen-specific Abs are applicable for diagnostic use at multiple disease stages and the OIT-treatment course in patients with cow's milk allergy.
在食物过敏原口服免疫疗法(OIT)的早期阶段,患者体内的过敏原特异性抗体(Abs)、IgE和IgG4会增加;随后,成功的OIT治疗后,IgE水平下降,特异性IgG4水平上升。在OIT期间这些抗体的详细情况仍不清楚。我们开发了一种诊断工具,通过识别IgE或IgG4抗体类别所识别的表位,基于一种分析方法来评估OIT疗效和反应程度。使用肽微阵列结合合成肽的微孔板分析,在五种主要牛奶过敏原的氨基酸序列中,鉴定出14个在OIT患者血清样本中被IgE和/或IgG4广泛识别的表位。这组确定的14个表位阐明了每个患者血清样本中过敏原特异性IgE和IgG4的不同表位情况。此外,识别所有14个表位的抗体总信号等于所有单个表位特异性抗体信号之和。进一步观察到,14个表位-ALL的IgE浓度定量值与免疫化学发光法(ImmunoCAP)IgE值相关。这些发现强烈表明,识别表位-ALL的IgE和IgG4的量可能很容易用于衡量过敏严重程度。为了研究这种潜力,我们开发了一种免疫层析方法,可检测患者样本中的IgE和IgG4水平。本研究清楚地证明了所确定的14个表位及其混合物“表位-ALL”的有用性,以及免疫层析和微孔板分析这些简单可靠的方法,这些方法展示了过敏原特异性抗体的表位情况,适用于牛奶过敏患者多个疾病阶段和OIT治疗过程中的诊断用途。